mRNA platform
A vaccine-design approach that delivers synthetic messenger-RNA instructions to a person's cells, prompting them to temporarily produce a target antigen for the immune system to learn.
How researchers study it
Messenger RNA was identified in 1961 as the cellular intermediate that carries genetic instructions from DNA to the protein-making ribosomes. The idea of using synthetic mRNA as a therapy traces back to research by Katalin Karikó and Drew Weissman, who in 2005 published a modification — substituting pseudouridine for uridine — that drastically reduced unwanted inflammatory responses to lab-made mRNA (Karikó & Weissman, Immunity, 2005, PubMed 16111635). They received the Nobel Prize in Physiology or Medicine in 2023 for this work.
In an mRNA vaccine, the synthetic mRNA encodes a target antigen — for COVID-19 vaccines, a pre-fusion-stabilized spike protein. The mRNA is wrapped in lipid nanoparticles, which fuse with cell membranes and deliver the mRNA into the cytoplasm. Ribosomes translate the mRNA into the spike protein, which is then displayed on the cell surface or released; immune cells learn to recognize it. The mRNA itself does not enter the cell nucleus and does not integrate into DNA, per the CDC's mechanism summary.
Pharmacokinetic studies show the mRNA and the protein it encodes are detectable in the body for a limited window — typically days to a few weeks for the mRNA, with spike protein detection extending somewhat longer in some studies (Röltgen et al., Cell, 2022, PubMed 35438856). Research into longer-term persistence in specific tissue reservoirs is ongoing.
Common misconceptions
- Karikó K, Weissman D. "Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA." Immunity, 2005. PubMed: 16111635
- CDC. "COVID-19 vaccines: clinical considerations." cdc.gov
- Röltgen K et al. "Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination." Cell, 2022. PubMed: 35438856